library Email this page members only
about uscib global network what's new
    Search      
Home Policy Advocacy: USCIB Committees and Working Groups Dispute Resolution: USCIB and ICC Arbitration Calendar of Events: USCIB and Partner Events Trade Services: USCIB Services to Facilitate U.S. Exports/Imports ATA Carnet: USCIB's Duty-Free and Tax-Free Temporary Exports/Imports
USCIB

Committee Officers

Arbitration

Banking

Biotechnology

China

Competition

Corporate Responsibility

Customs & Trade Facilitation

Emerging Markets

Energy

Environment

European Union

Financial Services

Food & Agriculture

Health Care

Information, Communications & Technology

Intellectual Property

Labor & Employment

Manhattan India Investment Roundtable

Marketing & Advertising

Nanotechnology

Product Policy

Taxation

Trade and Investment

Transportation

contact us
membership info
membership info

Committee Profile

Health Care

  

Background

Current debates surrounding provision of health care and health care systems address such business issues as: bringing medical and technological innovation to the market, provision and financing of health care, the balance of responsibilities between government, employer and individual, and the growth of genomics. These issues, which are being discussed at the OECD, United Nations, WHO and International Labor Organization, are of direct interest to the health care industries and to all employers.

 

Objective

Provide intergovernmental organizations with timely and objective information, expertise and policy advice on the broader economic and social consequences of national health care policies; the long-term innovative potential of the health care sector and the broader health ecosystem; the quality and costs of health care labor and technology; and the health care related impacts on capacity of employers to compete and provide jobs and support their employees.

 

Current Priorities

·         Through BIAC engagement in the OECD, promote a regulatory environment conducive to a wide range of health-related innovation and its diffusion; and support development of robust comparative health sector data as basis for developing health policy options.

 

 

 

Chair

Chris Gray

Senior Director, Global Institutions

Pfizer Inc

 

Staff Contacts

Helen Medina

Director – Life Sciences and Product Policy

(212) 703-5047 or hmedina@uscib.org

 

 Kira Yevtukhova

 Program Assistant

 (212) 703-5082 or kyevtukhova@uscib.org

 

·         Engage with US and foreign government officials and OECD staff to provide US business input into the development of the 2010 OECD Health Ministerial and to ensure business participation in the Ministerial in October 2010.

·         Encourage the OECD to adopt a multi-stakeholder approach to health care solutions; promote joint perspective of different government branches and broad representation of business and industry from all sectors.

 

·         Support OECD work recognizing emerging issues in global health-related innovation and internationalization of health care delivery, including IPR and migration of medical professionals.

 

 

Recent Accomplishments

·         Organized a multistakeholder luncheon during the UN Civil Society Hearings on Non-communicable Diseases (NCD’s) in June 2011 and prepared business input into the UN High Level Meeting on NCD’s in September 2011.

 

·         Participated in BIAC meetings with OECD Health Committee and its Secretariat to provide input for the preparation of the 2010 OECD Health Ministerial.

·         Met with US government officials and OECD staff to recommend that OECD governments take a horizontal approach to addressing health care challenges and that the OECD Health Committee’s work should support and reflect the OECD horizontal approach on innovation strategy.

·         Organized meeting with OECD Health Secretariat to provide input for the OECD’s project on the economics of the prevention of lifestyle related chronic diseases which resulted in having US business comments reflected in most recent OECD report on “Summary of findings and policy implications concerning the prevention of chronic diseases linked to unhealthy diets and sedentary lifestyles”.

·         Delivered international industry submission to OECD Experts Meeting on pharmaceutical pricing policy.

·         Secured speaking role for US business representative at the OECD High-level Symposium on pharmaceutical pricing policy.

·         Led participation in a business-led high-level briefing to the OECD on ICT in Health.

 





ALL RIGHTS RESERVED 2013 | PRIVACY POLICY STATEMENT | CONTACT US